RICERCA ITALIANA     

Programmi di ricerca simili:

• 1 - Nuove prospettive sull'immunità innata e l'immunoterapia.
• 2 - ANALISI MOLECOLARE DEI CLONI B-CELLULARI DOMINANTI NELL'INFEZIONE CRONICA DA HCV PER LA COSTRUZIONE DI FRAMMENTI Fab FUNZIONALI NEI PAZIENTI CON LINFOPROLIFERAZIONE BENIGNA E MALIGNA
• 3 - Apoptosi e terapia del cancro: caratterizzazione di nuovi meccanismi e nuove molecole modulatrici dell'apoptosi
• 4 - Nuove strategie immunomodulatorie nella Malattia di Graves: ruolo delle chemochine e delle cellule T regolatorie
• 5 - Sistema nervoso centrale e periferico ed infezione da virus dell'epatite C: manifestazioni clinico-patologiche, potenziali fattori favorenti la neuro-invasione, meccanismi del danno neurale.
• 6 - Il fattore di trascrizione NF-kB nella regolazione del differenziamento ed apoptosi del sistema immune.
• 7 - Ruolo dell'FGFR2 e di altri cofattori nell'etiopatogenesi di tumori epiteliali.
• 8 - Cellule Staminali Cardiache Umane e loro potenziale rigenerativo
• 9 - IMMUNITA' INNATA E MALATTIA CELIACA
• 10 - Medulloblastoma: studio delle vie molecolari di sviluppo e progressione tumorale allo scopo di identificare approcci terapeutici innovativi

Classificazione scientifico-disciplinare

• Area scientifico disciplinare: Scienze mediche
  • PATOLOGIA GENERALE
  • ONCOLOGIA MEDICA
  • MICROBIOLOGIA E MICROBIOLOGIA CLINICA
  • MALATTIE CUTANEE E VENEREE
  • MEDICINA DEL LAVORO

Classificazione brevettuale

• CHEMISTRY; METALLURGY
  • BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
  • ORGANIC CHEMISTRY (such compounds as the oxides, sulfides, or oxysulfides of carbon, cyanogen, phosgene, hydrocyanic acid or salts thereof C01; products obtained from layered base-exchange silicates by ion-exchange with organic compounds such as ammonium, phosphonium or sulfonium compounds or by intercalation of organic compounds C01B33/44; macromolecular compounds C08; dyes C09; fermentation products C12; fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture C12P; production of organic compounds by electrolysis or electrophoresis C25B3/00, C25B7/00)
    • PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
• HUMAN NECESSITIES
  • MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES (bringing into special physical form A61J [N: mechanical aspects]; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; compounds per se C01, C07, C08, C12N; soap compositions C11D; micro-organisms per se C12N) [C0203]

Classificazione geografica

• Regione: Lombardia

Bibliografia

1- Herrmann K, et al (2003). Epstein-Barr virus-associated carcinomas: facts and fiction. J Pathol, 199: 140.
2- Kinlen LJ (1998). Infection and childhood leukemia. Cancer causes, 9, 237.
3- Mortreux F, et al (2003). Molecular and cellular aspects of HTLV-1 associated leukemogenesis in vivo. Leukemia, 17: 26.
4- Walboomers JM, et al (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol, 189: 12.
5- zur Hausen H (2002). Papillomaviruses and cancer: from basic studies to clinical application. Nature Rev Cancer, 2: 342.
6- Hino O, et al (2002). Understanding the hypercarcinogenic state in chronic hepatitis: a clue to the prevention of human hepatocellular carcinoma. J Gastroenterol, 37: 883.
7- De Re V, et al (2000). Hepatitis C virus, non Hodgkin's lymphomas and hepatocellular carcinoma. Br J Cancer, 77: 2032.
8- Kedes DH, et al (1996). The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission. Nature Med, 2: 918.
9- Strickler HD, et al (1999). Human herpesvirus 8 cellular immune responses in homosexual men. J Infect Dis, 180: 1682.
10- Brambilla L, et (2000). Human herpesvirus-8 infection among heterosexual partners of patients with classical Kaposis's sarcoma. Br J Dermatol, 143: 1021.
11- Ensoli B, et al (2001). Biology of Kaposi's sarcoma. Eur J Cancer, 37: 1251.
12- Smith MJ, et al (2001). Lymphocyte-mediated immunosurveillance of epithelail cancers? Trends Immunol, 22: 409.
13- Carbone A, et al (2005). Kaposi's Sarcoma-associated herpesvirus/human herpesvirus type 8-positive solid lymphomas. A tissue-based variant of primary effusion lymphoma. J Mol Diagn, 7: 17.
14- Deloose STP, et al (2005). High incidence of Kaposi sarcoma-associated herpesvirus infection in HIV-related solid immunoblastic/plasmablastic diffuse large B-cell lymphoma. Leukemia, 1-5.
15- Boshoff C, et al (2001). Cancer processes in immunodeficient populations: an introduction. Eur J Cancer, 37: 1202.
16- Peto J (2001). Cancer epidemiology in the last century and the next decade. Nature, 411: 390.
17- Boshoff C, et al (2002). AIDS-related malignancies. Nature Rev Cancer, 2: 373.
18- Birkeland SA, et al (1995). Cancer risk after renal transplantation in the Nordic countries. Int J Cancer, 60: 183.
19- Aboulafia DM (2001). Kaposi's sarcoma. Clinics Dermatol, 19: 269.
20- Tindle RW (2002) Immune evasion in human papillomavirus-associated cervical cancer. Nature Rev Cancer, 2: 1.
21- Bontkes HJ, et al (1998). Specific HLA class I down-regulation is an early event in cervical dysplasia associated with clinical progression. Lancet, 351: 187.
22- Coscoy L, et al (2000). Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis. Proc Natl Acad Sci USA, 97: 8051.
23- Chouaib S, et al (1997). The host-tumor immune conflict: from immunosoppression to resistance and destruction. Immunol Today, 18: 493.
24- Shu S, et al (1997). Tumor immunology. JAMA, 278: 1972.
25- O'Hara RJ, et al (1998). Advanced colorectal cancer is associated with impaired interleukin 12 and enhanced interleukin 10 production. Clin Cancer Res, 4: 1943.
26- Jacobs NS, et al (1998). Inverse modulation of IL-10 and IL-12 in the blood of women with preneoplastic lesions of the uterine cervix. Clin Exp Immunol, 111: 219.
27- Merendino RA, et al (1999). Interleukin-12 and interleukin-10 production by mononuclear phagocytic cells from breast cancer patients. Immunol Lett, 68: 355.
28- Della Bella S, et al (2003). Altered maturation of peripheral blood dendritic cells in patients with breast cancer. Br J Cancer, 89: 1463.
29- Clerici M, et al (1998). Cytokine dysregulation in invasive cervical carcinoma and other human neoplasias: time to consider the TH1/TH2 paradigm. J Natl Cancer Inst, 90: 261.
30- Clerici M, et al (1997). Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection. J Natl Cancer Inst, 89: 245.
31- Clerici M, et al (1994). Multiple defects of T helper cell function in newly diagnosed patients with Hodgkin's disease: correlation of interleukin-2 production with hematologic parameters. Eur J Cancer, 30: 1464.
32- Villa ML ,et al (1993). Retinoids, breast cancer and NK cells. Brit J Cancer, 68: 845.
33- Nakayama Y, et al (2000). Serum levels of interleukin-12 in patients with gastrointestinal cancer. Anticancer Res, 20: 635.

Parole Chiave

VIRUS ONCOGENI, HUMAN HERPESVIRUS 8, HIV, IMMUNITA', CELLULE DENDRITICHE, CITOCHINE